Julia Hoefer

1.0k citations

18 papers · 828 indexed · h-index 14

Impact in

Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Pulmonary and Respiratory Medicine top 10%
- Prostate Cancer Treatment and Research

Papers in ⓘ

Cancer Research 6
- Cancer, Lipids, and Metabolism 4
Pulmonary and Respiratory Medicine 10
- Prostate Cancer Treatment and Research 10

Co-authors: Zoran Čulig (13 shared papers)Martin Puhr (11 shared papers)Helmut Klocker (9 shared papers)Isabel Heidegger (7 shared papers)Holger H.H. Erb (5 shared papers)Georg Schäfer (5 shared papers)Hannes Neuwirt (3 shared papers)Florian Handle (8 shared papers)
Journals: Oncogene (3 papers)American Journal Of Pathology (2 papers)Oncotarget (2 papers)Molecular Cancer Research (1 paper)Clinical Cancer Research (1 paper)
Partner nations: Austria Germany Netherlands

In The Last Decade

Julia Hoefer

18 papers receiving 817 citations

Peers

Countries citing papers authored by Julia Hoefer

Since Specialization

Citations

This map shows the geographic impact of Julia Hoefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Hoefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Hoefer more than expected).

Fields of papers citing papers by Julia Hoefer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Hoefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Hoefer. The network helps show where Julia Hoefer may publish in the future.

Co-authors

The 25 scholars most cited alongside Julia Hoefer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Julia Hoefer Line = papers co-authored together Julia Hoefer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205 American Journal Of Pathology ·Martin Puhr, Julia Hoefer, Georg Schäfer, Holger H.H. Erb, Su Jung Oh, Helmut Klocker, Isabel Heidegger, Hannes Neuwirt, Zoran Čulig	2012	211
2	The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy Clinical Cancer Research ·Martin Puhr, Julia Hoefer, Andrea Eigentler, Christian Ploner, Florian Handle, Georg Schaefer, Jan Kroon, Angela Leo, Isabel Heidegger, Iris E. Eder, Zoran Čulig, Gabri van der Pluijm, Helmut Klocker	2017	129
3	PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21 American Journal Of Pathology ·Julia Hoefer, Georg Schäfer, Helmut Klocker, Holger H.H. Erb, Ian G. Mills, Ludger Hengst, Martin Puhr, Zoran Čulig	2012	69
4	Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide Oncotarget ·Julia Hoefer, Mohammady Akbor, Florian Handle, Philipp Ofer, Martin Puhr, Walther Parson, Zoran Čulig, Helmut Klocker, Isabel Heidegger	2016	46
5	The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice PLoS ONE ·Ivan Tancevski, Egon Demetz, Kathrin Eller, Kristina Duwensee, Julia Hoefer, Christiane Heim, Ursula Stanzl, Andreas Wehinger, Kristina Auer, Regina Karer, Julia Huber, Wilfried Schgoer, Miranda Van Eck, Jonathan Vanhoutte, Catherine Fiévet, Frans Stellaard, Mats Rudling, Josef R. Patsch, Andreas Ritsch	2010	43
6	SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer Endocrine Related Cancer ·Julia Hoefer, Johann Kern, Philipp Ofer, Iris E. Eder, Georg Schäfer, Dimo Dietrich, Glen Kristiansen, Stephan Geley, Johannes Rainer, Eberhard Gunsilius, Helmut Klocker, Zoran Čulig, Martin Puhr	2013	41
7	PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer Oncogene ·Martin Puhr, Julia Hoefer, Andrea Eigentler, Dimo Dietrich, Geert van Leenders, Barbara Uhl, Marije Hoogland, Florian Handle, Bettina Schlick, Hannes Neuwirt, Verena Sailer, Glen Kristiansen, Helmut Klocker, Zoran Čulig	2015	39
8	SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells Molecular Cancer Research ·Florian Handle, Holger H.H. Erb, Birgit Luef, Julia Hoefer, Dimo Dietrich, Walther Parson, Glen Kristiansen, Frédéric R. Santer, Zoran Čulig	2016	36
9	The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models Molecular Cancer Therapeutics ·Florian Handle, Martin Puhr, Georg Schaefer, Nicla Lorito, Julia Hoefer, Martina Gruber, Fabian Guggenberger, Frédéric R. Santer, Rute B. Marques, Wytske M. van Weerden, Frank Claessens, Holger H.H. Erb, Zoran Čulig	2018	36
10	The “Aging Factor” Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor’s Age Frontiers in Aging Neuroscience ·Julia Hoefer, Markus Luger, Christian Dal‐Pont, Zoran Čulig, Harald Schennach, Stefan Jochberger	2017	36
11	PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells Oncotarget ·Martin Puhr, Julia Hoefer, Hannes Neuwirt, Iris E. Eder, Johann Kern, Georg Schäfer, Stephan Geley, Isabel Heidegger, Helmut Klocker, Zoran Čulig	2014	30
12	The thyromimetic T-0681 protects from atherosclerosis Journal of Lipid Research ·Ivan Tancevski, Andreas Wehinger, Egon Demetz, Julia Hoefer, Kathrin Eller, E. Huber, Ursula Stanzl, Kristina Duwensee, Kristina Auer, Wilfried Schgoer, Volker Kühn, Catherine Fiévet, Frans Stellaard, Mats Rudling, Bernhard Foeger, Josef R. Patsch, Andreas Ritsch	2008	29
13	Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR 2 EMBO Molecular Medicine ·Ivan Tancevski, Manfred Nairz, Kristina Duwensee, Kristina Auer, Andrea Schroll, Christiane Heim, Clemens Feistritzer, Julia Hoefer, Romana R. Gerner, Alexander R. Moschen, Ingrid Heller, Petra Pallweber, Xiaorong Li, Markus Theurl, Egon Demetz, Anna Wolf, Dominik Wolf‎, Kathrin Eller, Andreas Ritsch, Günter Weiß	2014	28
14	Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer Oncogene ·Martin Puhr, Andrea Eigentler, Florian Handle, Hubert Hackl, Christian Ploner, Isabel Heidegger, Georg Schaefer, Maximilian Peter Brandt, Julia Hoefer, Gabri van der Pluijm, Helmut Klocker	2021	26
15	Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner The Journal of Urology ·Shahrokh F. Shariat, Thomas Chromecki, Julia Hoefer, Christopher E. Barbieri, Douglas S. Scherr, Pierre I. Karakiewicz, Claus G. Roehrborn, Francesco Montorsi, Zoran Čulig, Ilaria T. Cavarretta	2011	13
16	Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts Oncogene ·Andrea Eigentler, Florian Handle, Silvia Schanung, Antonia Degen, Hubert Hackl, Holger H.H. Erb, Georgios Fotakis, Julia Hoefer, Christian Ploner, Karin Jöhrer, Isabel Heidegger, Andreas Pircher, Werner Klotz, Manfred Herold, Georg Schäfer, Zoran Čulig, Martin Puhr	2023	12
17	The ‘rejuvenating factor’ TIMP‐2 is detectable in human blood components for transfusion Vox Sanguinis ·Julia Hoefer, Christian Dal‐Pont, Stefan Jochberger, Raffaella Fantin, Harald Schennach	2020	3
18	Critical Role of Androgen Receptor Level in Prostate Cancer Cell Resistance to New Generation Antiandrogen Enzalutamide Endocrine Abstracts ·Julia Hoefer, Mohammady Akbor, Florian Handle, Philipp Ofer, Martin Puhr, Walther Parson, Zoran Čulig, Helmut Klocker, Isabel Heidegger	2016	1

About Julia Hoefer

Julia Hoefer is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Genetics, Oncology and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 828 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Estrogen and related hormone effects (6 papers), Cancer, Lipids, and Metabolism (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Ubiquitin and proteasome pathways (3 papers), Hormonal and reproductive studies (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Cancer Research (272 citations), Pulmonary and Respiratory Medicine (333 citations), Oncology (268 citations), Endocrinology, Diabetes and Metabolism (119 citations) and Molecular Biology (416 citations). Julia Hoefer has collaborated with scholars based in Austria, Germany and Netherlands. Frequent co-authors include Zoran Čulig, Martin Puhr, Helmut Klocker, Isabel Heidegger, Holger H.H. Erb, Georg Schäfer, Hannes Neuwirt, Florian Handle, Su Jung Oh and Andrea Eigentler. Their work appears in journals such as Oncogene, American Journal Of Pathology, Oncotarget, Molecular Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact